Clinical Trial Update: Phase I Study of LB-100 With Docetaxel in Solid Tumors [Phase 1]

View source ↗

Summary

A Phase I study evaluating LB-100 in combination with docetaxel for solid tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• LB-100 (LB-100)

Snippet

Sponsor: Lixte Biotechnology Holdings, Inc. | Conditions: Tumors, Neoplasms | Phase 1 | Status: COMPLETED